EXPRESSION OF S-100 PROTEIN IN CEREBRAL CORTEX IN THE MODELING OF ISCHEMIA UNDER CONDITIONS OF SENSITIZATION BY BRAIN ANTIGEN AND IMMUNE CORRECTION
DOI:
https://doi.org/10.11603/2415-8798.2017.4.8260Keywords:
brain ischemia, S-100 protein, sensitization, immunomodulation.Abstract
Ischemia is accompanied by diffuse damage of structural elements of brain: neurons, glia and intercellular contacts. One of the markers that demonstrate glial functional processes in nervous system is the S-100 protein.
The aim of the study – to learn the changes in the S-100 protein expression in the sensorimotor cortex of rats in conditions of induction of blood supply disorders in the basal region of the left carotid artery, against the background of a previous sensitization by brain antigen and with immunofun immunomodulator.
Materials and Methods. In the modeling of transient ischemia against the background of previous sensitization by brain antigen and immuno-immunofluorescence immunopharm, an experiment was conducted on 185 white, sexually mature male rats weighing 260–290 g. Histologic, immunohistochemical, morphometric and statistical methods of investigation were used.
Results and Discussion. The observations showed that sensitization by brain antigen induces neurodegenerative changes in the sensorimotor cortex and a slight decrease in the expression of S100 in neuropile, which is practically recovered after 22 days. However, there is an increase in this protein in the part of the gliocytes. Discirculatory changes that occurred in groups of animals with PO s and BCAs led to a slight increase in the expression of S100 in the cerebral cortex, the level of which did not significantly differ from the control values. Despite the fact that sensitization by brain antigen leads to a decrease in the expression of S100, there is an increase in neurodegenerative and destructive changes in the cerebral cortex and potentiation of the expression of S100 with the embolism of the microvessels of the brain on its background. The enhancement of the expression of S100 can be considered as systemic, since it is observed both from the side of the lesion and from the contralateral side, albeit to a lesser extent. The use of immunoaffinity in MEA s results in a less significant increase in S-100 expression and activation of astrocytes in response to transient impaired circulation in the sensorimotor cortex. Moreover, this effect, albeit less pronounced, is also observed on the contralateral side. Given that the differences in the expression of S100 with MEA s become valid from 22 (10) days after the start of the trial, it can be assumed that this is primarily due to modulation of the immune response, including the activation of the T-regulatory cell system serving in the quality of one of the neuroprotective factors that is activated after ischemia.
Conclusions. Sensitization by brain antigen induces neurodegenerative changes in the sensorimotor cortex and a slight decrease in the expression of S100 in neuropile and its growth in the part of the gliocytes. Sensitization by brain antigen leads to potentiation of the growth of S100 expression in response to transient coronary disturbance in the cerebral cortex. Immunophane significantly reduces the severity of neurodegenerative changes and reduces the growth of S100 expression caused by an ischemic attack as a violation of the circulatory system in the cerebral cortex and sensitization.
References
Mishchenko, T.S., Dariy, V.I. & Baranova, K.V. (2014). Vzayemozviazok zapalnykh ta protyzapalnykh markeriv u khvorykh v hostromu periodi mozkovykh insultiv [Interconnection of inflammatory and anti-inflammatory markers in patients with acute period of cerebral stroke]. Ukr. visnyk psykhonevrolohii – Ukr. Journal of Psychoneurology, 22, 2 (79), 16-18 [in Ukrainian].
Sahu, S., Nag, D.S., Swain, A. & Samadd, D.P. (2017). Biochemical changes in the injured brain. World J. Biol. Chem. Feb 26, 8 (1), 21-31.
Yin, R., Ma, A., Pan, X. & Yang, S. (2017). Biomarkers of cerebral microembolic signals. Clinica Chimica Acta, 475, 164-168.
Yaremenko, L.M. & Hrabovyi, O.M. (2009). Stan tytriv autoantytil do tkanynnykh antyheniv holovnoho mozku ta tsyrkulyuyuchykh imunnykh kompleksiv pry modeliuvanni porushen krovopostachannia holovnoho mozku riznoho stupeniu vazhkosti ta yoho korektsiia [The state of titers of autoantibodies to tissue antigens of the brain and circulating immune complexes in the modeling of cerebrovascular disorders of various degrees of severity and its correction]. Imunolohiia ta alerholohiia – Immunology and Allergology, 2-3, 55-59 [in Ukrainian].
Liesz, A., Suri-Payer, E. & Veltkamp, C. (2009). Regulatory T cells are key cerebroprotective immunomodulators in acute experimental stroke. Nature Medicine, 15, 192-199.
Karaulov, A.V. (2000). Molekulyarno-byolohycheskoe obosnovanyye prymenenyya ymunofana v klynycheskoy praktyke [Molecular-biological substantiation of imunofan application in clinical practice]. Lechashchyy vrach – The attending physician, 4, 46-47 [in Russian].
Adami C., Sorci G. & Blasi E. (2001). S100B Expression in and effects on microglia. Glia, 33, 131-142.
Nishiyama, H., Knopfel, T., Endo, S. & Itohara, S. (2002). Glial protein S100B modulates long-term neuronal synaptic plasticity. Proc. Natl Acad. Sci. USA, 99, 4037-4042.
Haupt, W.F., Chopan, Gh., Sobesky, J., Liu, Wei-Chi & Dohmen, Ch. (2016). Prognostic value of somatosensory evoked potentials, neuron-specific enolase, and S100 for short-term outcome in ischemic stroke. Journal of Neurophysiology, (115), 3, 1273-1278.
Marenholz, I., Heizmann, C.W. & Fritz G. (2014). S100 proteins in mouse and man: from evolution to function and pathology (including an update of the nomenclature). Biochem. Biophys. Res. Commun., (322), 1111-1122.
Heizmann, C.W. (2002). The multifunctional S100 protein family. Methods Mol. Biol., (172), 69-80.
Lee, B.W., Chae, H.Y. & Kwon, S.J. (2012). RAGE ligands induce apoptotic cell death of pancreatic B-cells via oxidative stress. J. Mol. Med., (26), 6, 813-818.
Tsoporis, J.N., Izhar, S. & Leong-Poi, H. (2010). S100B Interaction With the Receptor for Advanced Glycation End Products (RAGE) A Novel Receptor-Mediated Mechanism for Myocyte Apoptosis Postinfarction. Circulation Research, 106, 93-101.
Kumar, H., Lakhotia, M., Pahadiya, H., Singh, J., Sangappa, J.R. & Choudhary, A. (2016). Correlation of serum S-100 protein level with involvement of territory and size of lesion in acute ischemic stroke. International Jornal of Advanced Medical and Health Research, 3, 16-19.
Hurn, P.D. & Macrae, I.M. (2000). Estrogen as a neuroprotectant in stroke. J. Cereb. Dlood. Flow. Metab., (20), 631-652.
Hrabovyy, O.M. & Yaremenko, L.M. (2008). Pat. 36843 Ukraina, MPK G09B 23/00. Sposib modeliuvannia kombinovanoho sudynno-imunnoho poshkodzhennia mozku [Method of simulation of combined vascular-immune brain damage]. Zayavnyk y patentovlasnyk Natsionalnyi medychnyi universytet imeni O.O. Bohomoltsia – applicant and patentsman of the National Medical University. Bogomoltsya, No. u200806769; zayavl. 17.05.08; opubl. 10.11.08, Byul. No. 21 [in Ukrainian].
Yaremenko, L.M., Hrabovyy, O.M. Zapryvoda, L.P. & Kozak, H.I. (2015). Vplyv imunomoduliatsii na ekspresiiu bilku S-100 u sensomotorniy kori shchuriv pry modeliuvanni porushen tserebralnoho krovoobihu [Influence of immunomodulation on the expression of S-100 protein in the sensorimotor bone of rats in the modeling of cerebrovascular events]. Aktualni pytannia medychnoi nauky ta praktyky: Zb. nauk. pr. DZ «ZMAPO MOZ Ukrayiny» – Actual questions of medical science and practice: Zb. sciences DZ "ZMAPO of the Ministry of Health of Ukraine", (2), K. 2, Zaporizhzhya, 146-151.
Walsh, J.T., Zheng, J., Smirnov, I. & Walsh, T. (2014). Regulatory T cells in central nervous system injury: a double-edged sword. Journal of immunology (Baltimore, Md: 1950), (193), 10, 5013-5022.
Downloads
Published
How to Cite
Issue
Section
License
Authors who sent their manuscript to "Вісник наукових досліджень. Bulletin of Scientific Research" Surgery agree to the following terms:
a. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal. 
b. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
c. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access)
